`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`_______________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_____________
`
`SAMSUNG BIOEPIS CO., LTD.
`Petitioner,
`
`v.
`
`REGENERON PHARMACEUTICALS, INC.,
`Patent Owner.
`
`Patent No. 11,253,572
`
`_______________
`
`Inter Partes Review No. IPR2023-00884
`____________________________________________________________
`
`PATENT OWNER’S MOTION FOR PRO HAC VICE ADMISSION OF
`DARALYN J. DURIE UNDER 37 C.F.R. § 42.10(c)
`
`
`
`
`
`
`IPR2023-00884
`
`I.
`
`Relief Requested
`
`
`
`Pursuant to 37 C.F.R. § 42.10, Patent Owner Regeneron Pharmaceuticals,
`
`Inc., requests that the Board admit Daralyn J. Durie pro hac vice in this
`
`proceeding.
`
`II.
`
`Statement of Facts Showing Good Cause for the Board to Recognize
`Counsel Pro Hac Vice During the Proceeding
`
`In accordance with 37 C.F.R. § 42.10(c), the Board may recognize counsel
`
`pro hac vice during a proceeding, subject to the conditions set forth therein, and
`
`any others that the Board may impose. Patent Owner sets forth these facts in
`
`support of this motion:
`
`1.
`
`The undersigned contacted counsel for Petitioner (Quinn Emanuel
`
`Urquhart & Sullivan LLP), who indicated that Petitioner did not plan to oppose
`
`Ms. Durie’s admission pro hac vice.
`
`2.
`
`Lead counsel for Patent Owner, Regeneron Pharmaceuticals, Inc.,
`
`Adam Brausa, and Backup counsel, Rebecca Weires are registered practitioners.
`
`3.
`
`Daralyn J. Durie is an experienced litigator and has established
`
`familiarity with the subject matter at issue in this proceeding. Accompanying this
`
`motion is Exhibit 2061, the Declaration of Daralyn J. Durie in Support of this
`
`Motion for Admission Pro Hac Vice (“Durie Decl.”). In her declaration, Ms.
`
`Durie attests, among other things, that she is a member in good standing of the
`
`California Bar. Durie Decl. ¶¶ 1-2. Ms. Durie has never been subject to
`
`
`
`1
`
`
`
`IPR2023-00884
`
`
`
`suspensions or disbarments from practice, nor had applications for admission to
`
`practice denied, nor been subject to any sanctions or contempt citations by any
`
`court or administrative body. Durie Decl. ¶¶ 3-5.
`
`4. Ms. Durie has over 16 years of experience litigating patent cases
`
`involving biotechnology. Durie Decl. ¶ 9. As is relevant to this matter, Ms. Durie
`
`has litigated a number of cases relating to methods of treatment using antibodies.
`
`Id. In addition, Ms. Durie’s familiarity with the subject matter at issue in this
`
`proceeding is demonstrated by her review of the ’572 Patent, all cited prior art, and
`
`the IPR petition in this matter. Durie Decl. ¶ 10.
`
`5.
`
`In her declaration, Ms. Durie also attests to her admission to practice
`
`in other courts, as well as each of the required items set forth by 37 C.F.R.
`
`§42.10(c) and Unified Patents, Inc. v. Parallel Iron, LLC, IPR2013-00639, Paper 7
`
`(PTAB Oct. 15, 2013). See Durie Decl. ¶¶ 1-10.
`
`III. Conclusion
`
`For the foregoing reasons, Patent Owner respectfully request that the Board
`
`admit Daralyn J. Durie pro hac vice in this proceeding.
`
`
`
`
`
`
`
`
`
`
`
`2
`
`
`
`IPR2023-00884
`
`Date: December 21, 2023
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully Submitted,
`
`By: /Adam R. Brausa/
`Adam R. Brausa, Reg. No. 60,287
`MORRISON & FOERSTER LLP
`425 Market Street
`San Francisco, California 94105
`Tel: (415) 268-6053
`ABrausa@mofo.com
`
`Counsel for Patent Owner
`
`3
`
`
`
`IPR2023-00884
`
`Certificate of Service (37 C.F.R. § 42.6(e)(4))
`
`I hereby certify that the attached PATENT OWNER’S MOTION FOR PRO
`
`HAC VICE ADMISSION OF DARALYN J. DURIE UNDER 37 C.F.R. §
`
`42.10(c) and THE SUPPORTING DECLARATION OF DARALYN J. DURIE,
`
`were served on the date listed below via email (by agreement) upon the following
`
`counsel of record for Petitioner:
`
`Raymond N. Nimrod (Reg. No. 31,987)
`Matthew A. Traupman (Reg. No. 50,832)
`Landon Andrew Smith (Reg. No. 79,248)
`QUINN EMANUEL URQUHART
`& SULLIVAN, LLP
`51 Madison Ave., 22nd Floor
`New York, NY 10010
`Email: raynimrod@quinnemanuel.com
`Email: matthewtraupman@quinnemanuel.com
`Email: landonsmith@quinnemanuel.com
`Email: qe-samsungbioepis@quinnemanuel.com
`
`Dated: December 21, 2023
`
`/Adam R. Brausa/
`Adam R. Brausa, Reg. No. 60,287
`
`4
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
